independent valuation and credit value adjustment · pdf fileindependent valuation and credit...
TRANSCRIPT
Independent Valuation and Credit Value Adjustment (CVA)
Investment Management Association of Singapore (IMAS)
11 Feb 2015
Alvin Lee
The Science of Finance
\ 2
Agenda
Valuation Regulations
─ SFA 04-G05: Independent valuation
─ FRS 113: Credit valuation adjustment (CVA)
─ International regulations
─ Use cases beyond regulations
Best Practices: Independent Valuation
─ Broad product coverage
─ Automated and transparent workflow
─ Comprehensive market data
Best Practices: Credit Valuation Adjustment
─ Advanced calculation methodology
─ Extensive counterparty credit data
─ Determine materiality of CVA
Valuation Regulations
\ 4
Securities and Futures Act: SFA-04-G05
http://www.mas.gov.sg/Regulations-and-Financial-Stability/Regulations-Guidance-and-Licensing/Securities-Futures-and-Funds-
Management/Guidelines/2012/Guidelines.aspx
\ 5
SFA-04-G05: Independent valuation
\ 6
IOSCO FR05/13
http://www.iosco.org/library/pubdocs/pdf/IOSCOPD413.pdf
\ 7
IOSCO FR05/13: Valuation policies and procedures
\ 8\ 8
Some High Profile Losses
September 2013 – Two traders at a US Bank charged by the US department of Justice with five criminal counts over their alleged roles in trying to hide part of a $6.2 billion trading loss by mis-marking the values of positions in a credit portfolio
The bank agreed to pay approximately $920 million in fines to various regulators. The OCC and SEC made the following comments respectively:
Auditors and Regulators: “[The bank] did not provide an adequate foundation to identify, understand, measure, monitor and control risk … [the bank] failed to keep watch over its traders as they overvalued a very complex portfolio to hide massive losses”
When valuations are not independent
\ 9
Financial Reporting Standards: FRS 113
http://www.asc.gov.sg/frsArchives2004to2012# > Financial Reporting Standards > FRS 113
\ 10
FRS 113: Credit valuation adjustment (CVA)
Principle Paragraph Extract
CVA 42
“The fair value of a liability reflects the effect of non-performance risk. Non-performance risk includes, but may not be limited to, an entity’s own credit risk … Non-performance risk is assumed to be the same before and after the transfer of the liability.”
Exit Price IN8“fair value as the price that would be received to sell an asset or paid to transfer a liability”
Risk Pricing IN9
“When measuring fair value, an entity uses the assumptions that market participants would use when pricing the asset or liability under current market conditions, including assumptions about risk.”
Observable
InputsIN10(d)
“maximise the use of relevant observable inputs and minimise unobservable inputs”
Same Inputs
as PricingIN10(d)
“inputs should be consistent with the inputs a market participant would use when pricing the asset or liability.”
\ 11
FRS 113: Credit valuation adjustment (CVA)
Principle Paragraph Extract
Own Credit
Risk42
“Non-performance risk includes, but may not be limited to, an entity’s own credit risk”
Portfolio
Netting48
“exception permits an entity to measure the fair value of a group of financial assets and financial liabilities on the basis of the price that would be received to sell a net long position … or paid to transfer a net short position”
Credit
Mitigation56
“take into account any existing arrangements that mitigate credit risk exposure in the event of default (eg a master netting agreement with the counterparty or an agreement that requires the exchange of collateral)”
Calibration 64
“valuation technique shall be calibrated so that at initial recognition the result of the valuation technique equals the transaction price … After initial recognition, … an entity shall ensure that those valuation techniques reflect observable market data”
\ 12
International regulations
AIFMD IPV, Risk for European non-UCITS funds
UCITS III & IV IPV, Risk for all UCITS funds
Solvency II Prescriptive stress testing for insurers
EMIR, Dodd-Frank Valuations, Reporting, CCPs, IM/VM
IFRS 9, Topic 815 Accounting at fair value as exit price
IFRS 13, Topic 820 Fair value framework, CVA/DVA
IFRS 7 Credit and market risk disclosures
AIMA, IOSCO, HFSB IPV as best practice for hedge funds
Independent valuation … of internal and counterparty marks
Consistency, automation … to mitigate operational risk
Regula
tions
Accounting
Guid
elin
es
\ 13
Independent valuations not just for regulatory compliance
─ Net Asset Value (NAV) calculation
─ Fair value for financial reporting and hedge accounting
─ Benchmarking of counterparty marks, internal valuation
─ Calculation of variation margin for collateral disputes
─ Risk management, scenario analysis and stress testing
─ Submission to trade repository
Use cases beyond regulations
Best Practices: Independent Valuation
\ 15
150+ product types currently priced for clients globally
Broad product type coverage
Cash
CLOs, CMOs
Corporate / Municipal / Sovereign bonds
European ABS
Leveraged loans
US ABS / RMBS / CMBS
Commodity
Barrier options
Bespoke commodity products
Caps / Floors
Forwards
Swaps / TRS
Variance swaps
Credit
Asset backed CDS
Asset swaps
Bespoke credit products
CDO tranches (synthetic)
CDS (single name and index)
Commercial mortgage backed CDS
Credit default swap baskets
Credit linked notes
Loan CDS
Options on CDS indices
Recovery locks
Structured finance indices
Total return swaps
Equity
Accrual options
Accumulators
Altiplanos
Asian options
Atlas
Auto-callables
Barrier options
Basket options
Basket swaps
Basket TRS
Bespoke equity products
Best / worst of basket and barrier options
Cliquets
Contracts for difference
Convertible bonds
Corridor variance swaps
Crescendo auto-callables
Currency translated options
Digital options
Dispersion options
Dividend swaps
Double Asian options
Forwards
Freezer
Himalayan options
Index correlation swaps
Ladder options
Lookbacks
Outperformance options and autocallables
Quanto options
Range accruals (knockout, callable)
TARNs
Variance options and swaps (conditional)
FX
Accumulator options and forwards
American options
Asian options
Barrier options
Barrier exotics (multiwindow, quanto etc.)
Bespoke FX products
Best / worst of options
Co-Dependent digital options
Convex options
Currency swaps
Digital options (outperformance)
Double Asian options
Fader
Forward volatility agreements
Forwards
Lookbacks
NDFs
Quanto options
Range accruals (knockout, callable)
TARKO
Variance budget options
Variance swaps
Volatility swaps
Private Equity
Unlisted equity
Illiquid debt
Interest Rates
American swaptions
Amortizing swaps and swaptions
Basis swaps
Bermudan swaptions
Bespoke interest rate products
Bond options
Bond TRS
Caps / Floor (callable, flipper)
Callable swaps
CMS spread options (quanto, digital)
CMS swaps, caps / floors
Contingent swaptions
Cross currency IRS
Curve / annuity caps
Forward starting swaptions
FRAs
FVA swaption straddles
Inflation linked swaps
Inflation options
Longevity swaps
Mark-to-market swaps
OIS
PRDCs (callable, digital, trigger, etc.)
Price locks
Range accruals
Snowballs
Snowblades
TARNs
Zero coupon swaps
\ 16
Automated and audited workflow
XML
CSV
Web
PMS (e.g. Charles River)
Totem data
Valuation and Risk Calculations
External data
Valuation and risk reports
Analyst Viewer
(Excel)
XML
Markit data
Data
Cle
anin
g
Corrections to Trade Data
Quality Control:• Large P&L moves• Tolerance breaks• New trades• Revised trades• Market data review
Confirmation requests and price challenges
Database
(Warehouse)
WebserverScheduler
Webserver
Trade confirmations
(e.g. MarkitWire)
\ 17
Trade parameters
Viewable trade parameters
Trade details should be reviewed to verify
that valuation is based on accurate trade
representation
This is important as the majority of
valuation discrepancies are resolved by
correcting trade parameters.
\ 18
Market data
\ 19
Counterparty marks
\ 20
Discrepancy resolution
Resolution process
1. Trade economicsUnderlying trade detail review including analysis of termsheet or confirmation. Most challenges are closed out at this step.
2. Valuation settings
Account valuation rule review including configurations and settings. Examples include market data snap times and discounting methodologies.
3. Market inputs
Underlying market data review including comparison against counterparty market data. Examples include review of spots/fixings, curve, volatilities and correlations.
4. Models and methodology
Cash flow and detailed price calculation review. Detailed analysis by product
specialists and/or quantitative analysis team may be required.
\ 21
Market data Data sources
FX WM/Reuters, ECB, NDF. Volatilities bootstrapped from daily broker and Markit Totem consensus for ATM and OTM.
EquitiesExchange data (all major equity exchanges) via SIX Financial Information, Markit Distribution Platform and Markit Solutions. Corporate action and dividend data from Markit Equities and Exchange Data International. Volatilities from exchange data and Markit Totem consensus, incl. variance, volatility, dividend swaps.
CommoditiesExchange data (NYMEX, LME, ICE, CBOT etc) via Markit Distribution Platform and Markit Solutions. Daily broker and Markit Totem consensus for swaps, forwards and options.
Rates
Yield curve bootstrapped from daily broker/dealer quotes for deposits, futures, swaps, forward FX rates and cross-currency basis swaps, using OIS-LIBOR dual-currency methodology. Volatilities from daily broker ATM swaption volatilities, extended to OTM using monthly Markit Totem consensus. Inflation zero rates from Markit Totem consensus.
CreditSingle-name and index CDS consensus from main sell-side contributors via Markit CDS. Corporate actions via Markit RED. Volatilities and correlations from Markit Totem consensus.
Structured ProductsRespective spot, historical and volatility data as per each underlying asset. Implied correlations from Markit Totem consensus where available, otherwise historical correlation as proxy.
Cash Bond / LoansBond and loan pricing from active global sell-side desks via Markit Bonds and Markit Loans. Markit Evaluated Bonds for other cash bonds.
Structured Finance Daily contributed prices for cash ABS. Evaluated pricing for CMBS, CLO, CDO.
Private EquityComparable listed equity financial statements, comparable liquid debt from Markit Loans and Markit Evaluated Bonds database.
Comprehensive market data
Best Practices: Credit Valuation Adjustment
\ 23
FRS 113 fair value measurement of OTC derivatives requires the reporting of credit value adjustment (CVA) from 1st January 2013
Risk Pricing : “When measuring fair value, an entity uses the assumptions that market
participants would use … including assumptions about risk.”
International Financial Reporting Standards 13
Market participants using sophisticated approaches to calculate CVA
\ 24
— To quickly meet IFRS 13 compliance, used in-house simplified CVA approach
— Auditor expressed concern about methodology, especially:
— simplified present value-based approximation for future exposures
— historical probabilities of default
— Auditor required remediation plans to be put-in-place, and completed by following year-end reporting
Simplified CVA approach
“While a variety of less complex approaches exist, they typically focus on current exposure…
However, these approaches do not reflect different possible outcomes for the fair value at the point of default.”
IFRS 13 Fair Value Measurement: Credit valuation adjustments for derivative contracts, EY, April 2014
Simplified approach not compliant with IFRS 13
x
x
Typical experience of firms with significant OTC derivative positions
\ 25
Advanced calculation methodology
\ 26
Extensive counterparty credit data
Names in CDS universe
Proxy by name
Proxy using Markit Enhanced CDS Sector Curves
Name assigned with
1. Rating
2. Markit Sector
3. Region
Factor model
Function (Rating, Sector, Region)
Counte
rpart
y lis
t
─ Consumer goods─ Consumer services─ Government─ Industrials─ Utilities─ Basic materials
─ Energy─ Telecoms─ Financials─ Technology─ Healthcare
2.Sectors
3.Regions
─ Oceania─ Eastern Europe─ Middle East
─ North America─ Europe─ Japan─ Asia Ex-Japan
1.Ratings
─ AAA─ AA─ A
─ BBB─ BB ─ B
─ CCC
Rating Sector Region
\ 27
Portfolio characteristics
─ Cash, exchange-traded derivatives, OTC derivatives
─ Netting and collateral agreements
─ Counterparty risk
─ Portfolio and counterparty risk change over time
Materiality threshold
─ Qualitative assessment?
─ % of overall fund NAV? 10bps, 25bps, 50bps?
─ Calculate CVA to determine materiality, and then calculate CVA?
Determine materiality of CVA
\ 28
1. Local and international regulations require independent valuation and credit value adjustment
2. Additional use cases beyond regulatory compliance
3. Independent valuation best practices include broad product coverage, comprehensive data and automated processes
4. CVA best practices include advanced methodology, extensive credit data and materiality determination
Key Takeaways
mines data
pools intelligence
surfaces information
enables transparency
builds platforms
provides access
scales volume
extends networks
& transforms business.
The information contained in this presentation is confidential. Any unauthorised use, disclosure, reproduction or dissemination, in full or in part, in any media or by any means, without the prior written permission of Markit Group Holdings Limited or any of its affiliates ("Markit") is strictly prohibited.
Opinions, statements, estimates and projections in this presentation (including other media) are solely those of the individual author(s) at the time of writing and do not necessarily reflect the opinions of Markit. Neither Markit nor the author(s) has any obligation to update this presentation in the event that any content, opinion, statement, estimate or projection (collectively, "information") changes or subsequently becomes inaccurate.
Markit makes no warranty, expressed or implied, as to the accuracy, completeness or timeliness of any information in this presentation, and shall not in any way be liable to any recipient for any inaccuracies or omissions. Without limiting the foregoing, Markit shall have no liability whatsoever to any recipient, whether in contract, in tort (including negligence), under warranty, under statute or otherwise, in respect of any loss or damage suffered by any recipient as a result of or in connection with any information provided, or any course of action determined, by it or any third party, whether or not based on any information provided.
The inclusion of a link to an external website by Markit should not be understood to be an endorsement of that website or the site's owners (or their products/services). Markit is not responsible for either the content or output of external websites.
Copyright ©2014, Markit Group Limited. All rights reserved and all intellectual property rights are retained by Markit.
Disclaimer